Yadav Kapil, Arjun M C, Jacob Olivia Marie, Kant Shashi, Ahamed Farhad, Ramaswamy Gomathi
National Centre of Excellence and Advanced Research on Anemia Control, Centre for Community Medicine, All India Institute of Medical Sciences, New Delhi, India.
Centre for Community Medicine, All India Institute of Medical Sciences, New Delhi, India.
J Family Med Prim Care. 2020 Mar 26;9(3):1308-1316. doi: 10.4103/jfmpc.jfmpc_960_19. eCollection 2020 Mar.
Different doses of iron are used for oral supplementation during pregnancy throughout the world. This objective of this review is to describe the effectiveness and side effect profile of different doses of oral iron supplementation for prophylaxis of anemia among pregnant women. Published literature was searched using keywords "iron," "pregnancy," and "supplementation" and related terms. Gray literature was searched in medical libraries including National Medical Library, Dr. B. B. Dikshit library, and library of ICMR. Intervention studies comparing different doses of oral iron given as prophylaxis for anemia during pregnancy, published till December 2017, were retrieved. Studies done only among anemic patients, and studies comparing oral iron with placebo were excluded. In total, 1588 studies were obtained and 11 of them met the objectives. In global studies, prophylactic dose of 30 mg and above is shown to maintain normal hemoglobin. Among the studies from India, prophylactic dose of 120 mg showed consistent results and 60 mg showed inconsistent results in increasing both hemoglobin and ferritin levels. No significant difference in side effects was reported up to 80 mg iron in global studies and the side effects were comparable with 60 to 240 mg doses in Indian studies. It was evident from the review that a state of clinical equipoise exists for the ideal dose of iron supplementation for the prevention of anemia in pregnancy in terms of efficacy and side effect profile. Robust clinical trial as well as technical consultation is required, especially in Indian setting to explore this question further.
世界各地在孕期口服补铁时使用的铁剂量各不相同。本综述的目的是描述不同剂量口服补铁预防孕妇贫血的有效性和副作用情况。使用关键词“铁”“妊娠”“补充”及相关术语检索已发表的文献。在包括国家医学图书馆、B.B.迪克斯希特博士图书馆和印度医学研究理事会图书馆在内的医学图书馆中检索灰色文献。检索截至2017年12月发表的比较孕期口服不同剂量铁预防贫血的干预性研究。仅针对贫血患者开展的研究以及比较口服铁剂与安慰剂的研究被排除。总共获得1588项研究,其中11项符合研究目的。在全球研究中,30毫克及以上的预防剂量可维持血红蛋白正常。在印度的研究中,120毫克的预防剂量在提高血红蛋白和铁蛋白水平方面显示出一致的结果,而60毫克的结果不一致。在全球研究中,铁剂量达80毫克时未报告副作用有显著差异,在印度研究中,60至240毫克剂量的副作用相当。该综述表明,在预防孕期贫血的铁补充理想剂量方面,就疗效和副作用情况而言,目前存在临床 equipoise状态。需要开展有力的临床试验以及进行技术咨询,尤其是在印度背景下,以进一步探究这个问题。